Submission of Unaudited Quarterly Financial Results for the quarter and half year ended 30th September, 2025
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Nexus Surgical and Medicare Ltd reported Q2 FY26 revenue of Rs. 116.58 lakh, up about 17% from Rs. 99.49 lakh in Q2 FY25, while profit after tax fell to Rs. 17.37 lakh from Rs. 20.56 lakh YoY due to higher other expenses. For the half year (H1 FY26), revenue rose modestly to Rs. 289.11 lakh from Rs. 275.52 lakh, with PAT of Rs. 32.61 lakh vs Rs. 29.56 lakh earlier. EPS for H1 stood at Rs. 0.60 vs Rs. 0.54. The balance sheet shows other equity in negative territory at Rs. -408.21 lakh, against equity share capital of Rs. 547.19 lakh. Cash flow from operations was negative at Rs. -16.46 lakh for H1 FY26, and cash on hand dropped to Rs. 16.66 lakh from Rs. 33.13 lakh at the start of the year.
Despite slight top-line growth, shrinking cash reserves, negative operating cash flow, and accumulated losses in reserves are red flags for shareholders. The stock may see pressure as financial weakness outweighs the modest profit growth.